Ana Puhl | Associate Director
Collaborations Pharmaceuticals

Ana Puhl, Associate Director, Collaborations Pharmaceuticals

I am Senior Scientist at Collaborations Pharmaceuticals. I joined the company in 2018 and I am involved in drug discovery projects for rare genetic diseases, neglected diseases and antiviral research. At Collaborations, I am responsible for leading, managing and executing R&D projects in several therapeutic areas including Covid-19,  rare diseases (Batten CLN1, Sialidosis) and neglected diseases (Zika,Chikungunya, Malaria) and CNS diseased (Alzheimer). I am passionate about drug discovery and committed to find solutions to improve peoples’ lives. My background is protein crystallography, where I did a PhD at University of Sao Paulo, Brazil. I continue to pursue my education with Post-Doctoral studies at GlaxoSmithKline (USA), University of North Carolina (USA) and Fiocruz (Brazil).


WVIC/WAC Day 1 - Nov 29 @ 14:20

Applying machine learning for antiviral drug discovery

last published: 01/Dec/22 17:25 GMT

back to speakers

For conference programme and speaking opportunities:
Lauren Sheppard

For sponsorship and exhibition opportunities:
Thomas Hall